Pawan Gupta, Nipun Goyal & Mudit Vijayvergiya: Expert medical advice on the go with Curofy

Curofy helps doctors stuck with unusual cases by fetching responses from peers

Published: Feb 8, 2018

Starting out as a newswire journalist covering beats as diverse as business, politics, entertainment, crime, civic affairs, cricket and defence, I was keen to pursue a career in print or broadcast journalism. But the emerging world of multimedia storytelling promised a fascinating future, and I changed my focus to digital media more than a decade ago. Before Forbes India, I have worked for organisations such as ANI, Money Control, Arabian Business, Yahoo India and VFS Global. I hold master's degrees in Communication Studies (University of Pune, India) and Journalism (University of Westminster, London, UK).

g_103325_curofy_280x210.jpgFrom left: Pawan Gupta, Mudit Vijayvergiya and Nipun Goyal
Image: Amit Verma


Pawan Gupta | 26
Nipun Goyal | 27
Mudit Vijayvergiya | 27
Co-founders, Curofy

IIT-Delhi alumni Pawan Gupta, Nipun Goyal and Mudit Vijayvergiya are on a mission “to help doctors diagnose and cure faster”. Their company 911 India Healthcare owns Curofy, a networking mobile app where over 200,000 “verified” doctors discuss more than 400 cases every day.

Launched in 2015, the premise of Curofy is simple. Doctors coming across unusual cases that require further opinion can post anonymous images and necessary details on the app. From its database, Curofy identifies the right doctors, who can see the cases in their feeds or through push notifications. Within a few hours, the doctors in need receive an average of five to seven responses from their peers across various specialties.

Click here to view the full Forbes India 30 Under 30 list

Going forward, the company aims to “help other stakeholders use this engagement and reach out to doctors”, says Goyal. “All stakeholders who are creating value for doctors could use Curofy to create their own platforms or devices; so an app inside [the app].”

With a credible network, Curofy aims to scale up through brand promotions and marketing of pharmaceuticals, medical devices, and health-tech products and services. “Pawan, Mudit and Nipun bring a perfect combination of product expertise and domain passion to scale up this opportunity,” says Leo Capital’s Rajul Garg, who has invested in the venture.

Click here to view the full Forbes India 30 Under 30 list

g_103321_social_media_280x210.jpg


(This story appears in the 16 February, 2018 issue of Forbes India. You can buy our tablet version from Magzter.com. To visit our Archives, click here.)

Show More
Post Your Comment
Required
Required, will not be published
All comments are moderated
Vidit Aatrey & Sanjeev Barnwal: Redefining distribution with Meesho
Tarun Mehta & Swapnil Jain: Electrifying scooters